Global Women Health Diagnostic Market Executive Summary
The market is currently primarily driven by rising chronic and lifestyle disorders, increasing chronic illness awareness, and the high prevalence of infectious diseases including HIV and hepatitis in women around the world. During the projected period, this market's expansion is anticipated to be aided by rising POC diagnostic testing adoption rates as well as an increase in the number of diagnostic and imaging facilities. However, it is anticipated that this market's expansion will be limited to some extent by the high cost of diagnostic devices, tests, and procedures; a lack of qualified laboratory workers; and insufficient reimbursements for diagnostic tests.
Market Size and Key Findings
The Global Women Health Diagnostic Market size is at around US $ Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Women Health Diagnostic Market Size (In $Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
HIV in patients is frequently found with diagnostic tests such as POC testing. With a quick POC HIV test, doctors may inform patients of their HIV status and offer results all in the same appointment. Pre- and post-test patient counselling is not necessary, as is the case with conventional laboratory analysis. Women are more vulnerable to other sexually transmitted diseases (STDs) and associated long-term consequences in addition to HIV. In the US, STDs are a factor in more than 50% of cases of avoidable infertility. The majority of sexually transmitted infections can be transmitted to an unborn child or foetus, sometimes with lethal results. The management of infectious diseases, such as HIV, UTIs, and tuberculosis, can be improved by rapid POC tests, particularly in developing nations where prompt access to medical care is difficult and the healthcare infrastructures are antiquated.
Market Restraints
The majority of hospitals in developing nations cannot afford expensive diagnostic imaging equipment. MRI equipment typically costs between USD 1.5 million and USD 2.0 million, whilst CT machines are priced between USD 1.0 million and USD 1.5 million. Healthcare facilities like hospitals and diagnostic centres are hesitant to make large investments in pricey machinery due to the high cost of these systems and the limited financial resources of hospitals. When purchasing these pricey systems, healthcare facilities sometimes rely on third-party payers (such as Medicare, Medicaid, or commercial health insurance plans) to cover the expenses of the diagnostic and screening operations carried out utilising this equipment.
CompetitiveLandscape
Key Players
The leading companies in this industry are Becton, Dickinson and Company, Siemens AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., General Electric Company, and Quest Diagnostics
TABLE OF CONTENT
1. Report Description of the Global Women Health Diagnostic Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Women Health Diagnostic Market Executive Summary
2.1 Global Women Health Diagnostic Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Women Health Diagnostic Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Women Health Diagnostic Market Segmentation
4.1.6.2 Downs Syndrome and Edwards’ Syndrome Testing
4.1.6.3 TORCH Testing
4.1.6.4 Other Prenatal Genetic Disease Tests
4.1.7 Infectious Disease Testing
4.1.7.1 MRSA Testing
4.1.7.2 UTI Testing
4.1.7.3 Hepatitis Testing
4.1.7.4 Tuberculosis Testing
4.1.7.5 Other Infectious Disease Tests
4.1.8 STD Testing
4.1.8.1 CT/NG Testing
4.1.8.2 HIV Testing
4.1.8.3 Other STD Tests
4.1.9 Ultrasound Tests
4.1.9.1 Breast Imaging
4.1.9.2 OB/GYN Imaging
4.2 By End User
4.2.1 Hospitals & Clinics
4.2.2 Diagnostic and Imaging Centers
4.2.3 Home Care Settings
5. Global Biomaterials in Women Health Diagnostic Market
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Women Health Diagnostic Market
9. Factors Driving Future Growth
9.1 New Trends and Development Global Women Health Diagnostic Market
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Women Health Diagnostic Market Segmentation
By Application (Revenue, USD Billion):
The market for women's health diagnostics is divided into osteoporosis tests, OVC tests, cervical cancer tests, breast cancer tests, pregnancy and fertility tests, prenatal genetic screening and carrier tests, infectious disease tests, STD tests, and ultrasound tests based on the applications they are used for. Bone densitometry and in vitro blood tests are two other subcategories of osteoporosis testing. OVC testing is further divided into tests for tumour markers, imaging-based diagnostics, and further OVC assays. Pap tests and HPV tests are two additional subcategories of cervical cancer screening. Mammography, tumour marker tests, biopsies, and other breast cancer tests are other subcategories of breast cancer testing. Lab-based testing, pregnancy testing, and ovulation prediction kits, and fertility monitors are other subcategories of pregnancy and fertility testing. There are more sub-categories of prenatal genetic screening and carrier testing, including tests for Down's syndrome, Edwards syndrome, CF, and other prenatal genetic diseases. Testing for infectious diseases is further divided into MRSA, UTI, hepatitis, tuberculosis, and other infectious diseases tests. CT/NG testing, HIV testing, and other STD Tests are other subcategories of STD Testing. Breast imaging and OB/GYN imaging are additional sub-segmented types of ultrasound exams.
Osteoporosis Testing
Bone Densitometry
In Vitro Blood Tests
OVC Testing
OVC Tumor Marker Tests
OVC Diagnostic Imaging Tests
Other OVC Tests
Cervical Cancer Testing
Pap Smears
HPV Testing
Breast Cancer Testing
Mammography
Breast Cancer Tumor Marker Tests
Biopsies
Other Breast Cancer Tests
Pregnancy & Fertility Testing
Lab-based Testing
Pregnancy Testing & Ovulation Prediction Kits
Fertility Monitors
Prenatal Genetic Screening & Carrier Testing
CF Testing
Down’s Syndrome and Edwards’ Syndrome Testing
TORCH Testing
Other Prenatal Genetic Disease Tests
Infectious Disease Testing
MRSA Testing
UTI Testing
Hepatitis Testing
Tuberculosis Testing
Other Infectious Disease Tests
STD Testing
CT/NG Testing
HIV Testing
Other STD Tests
Ultrasound Tests
Breast Imaging
OB/GYN Imaging
By End User (Revenue, USD Billion):
On the basis of end-user, the womens health diagnostics market is segmented into spitals, diagnostic and imaging centers, clinics, and home care settings.
Hospitals & Clinics
Diagnostic and Imaging Centers
Home Care Settings
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
